Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


May 24, 2015 11:20 AM ET

Biotechnology

Company Overview of Tobira Therapeutics, Inc.

Company Overview

Tobira Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapeutics to treat liver diseases, human immunodeficiency virus (HIV)-1, kidney fibrosis, and inflammation. It offers cenicriviroc, an immumodulator and dual inhibitor of CCR2 and CCR5 for the treatment of non-alcoholic steatohepatitis (NASH), HIV, and others. The company was founded in 2006 and is based in South San Francisco, California.

701 Gateway boulevard

Suite 200

South San Francisco, CA 94080

United States

Founded in 2006

13 Employees

Phone:

650-741-6625

Key Executives for Tobira Therapeutics, Inc.

Chief Medical Officer
Age: 50
Total Annual Compensation: $335.0K
Compensation as of Fiscal Year 2013.

Tobira Therapeutics, Inc. Key Developments

Tobira Therapeutics, Inc. Presents at Bank of America Merrill Lynch 2015 Health Care Conference, May-13-2015 08:40 AM

Tobira Therapeutics, Inc. Presents at Bank of America Merrill Lynch 2015 Health Care Conference, May-13-2015 08:40 AM. Venue: Encore at the Wynn, 3131 S Las Vegas Blvd, Las Vegas, Nevada, United States.

Tobira Therapeutics, Inc.(NasdaqCM:TBRA) added to Russell 2000 Index

Tobira Therapeutics, Inc. has been added to Russell 2000 Index.

Tobira Therapeutics, Inc.(NasdaqCM:TBRA) added to Russell 3000 Index

Tobira Therapeutics, Inc. has been added to Russell 3000 Index.

Similar Private Companies By Industry

Company Name Region
Endogeny Bio Corporation United States
Enteris BioPharma, Inc. United States
Immuno Concepts N.A. Ltd. United States
Arvinas, Inc. United States
Applied Veterinary Systems United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
January 14, 2015
Regado Biosciences, Inc.
Private Placement
January 14, 2015
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Tobira Therapeutics, Inc., please visit www.tobiratherapeutics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.